Literature DB >> 11887985

Radiotherapy and combined modality approaches in localised prostate cancer.

D P Dearnaley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11887985     DOI： 10.1016/s0959-8049(01)80015-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Assessing of integration of ionizing radiation with Radachlorin-PDT on MCF-7 breast cancer cell treatment.

Authors:  R Ghoodarzi; V Changizi; A R Montazerabadi; N Eyvazzadaeh
Journal:  Lasers Med Sci       Date:  2015-12-21       Impact factor: 3.161

2.  Neoadjuvant LHRH analog plus estramustine phosphate combined with three-dimensional conformal radiotherapy for intermediate- to high-risk prostate cancer: a randomized study.

Authors:  Daisaku Hirano; Yusuke Nagane; Katsuhiko Satoh; Junichi Mochida; Shuji Sugimoto; Taketo Ichinose; Satoru Takahashi; Toshiya Maebayashi; Tsutomu Saitoh
Journal:  Int Urol Nephrol       Date:  2009-05-16       Impact factor: 2.370

3.  Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.

Authors:  D P Dearnaley; E Hall; D Lawrence; R A Huddart; R Eeles; C M Nutting; J Gadd; A Warrington; M Bidmead; A Horwich
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.